Search research articles
Contact Us
Filters
Showing results (21-30 of 28) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 28 results.
Thrombosis and Haemostasis
|
May 5, 2007
A novel P2Y(12) adenosine diphosphate receptor antagonist that inhibits platelet aggregation and thrombus formation in rat and dog models
Yi-Xin Wang, Jon Vincelette, Valdeci da Cunha, et al.
Circulation
|
April 27, 2005
Fasudil, a Rho-kinase inhibitor, attenuates angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice by inhibiting apoptosis and proteolysis
Yi-Xin Wang, Baby Martin-McNulty, Valdeci da Cunha, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 8, 2011
1-(1-acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia
Sampath-Kumar Anandan, Heather Kay Webb, Dawn Chen, et al.
The Journal of Biological Chemistry
|
September 5, 2019
Intracerebroventricular enzyme replacement therapy with β-galactosidase reverses brain pathologies due to GM1 gangliosidosis in mice
Joseph C Chen, Amanda R Luu, Nathan Wise, et al.
Molecular Therapy. Methods & Clinical Development
|
July 1, 2017
Clearance of Heparan Sulfate and Attenuation of CNS Pathology by Intracerebroventricular BMN 250 in Sanfilippo Type B Mice
Mika Aoyagi-Scharber, Danielle Crippen-Harmon, Roger Lawrence, et al.
Drug Delivery and Translational Research
|
January 17, 2020
Translational studies of intravenous and intracerebroventricular routes of administration for CNS cellular biodistribution for BMN 250, an enzyme replacement therapy for the treatment of Sanfilippo type B
Anita Grover, Danielle Crippen-Harmon, Lacey Nave, et al.
The Journal of Biological Chemistry
|
October 28, 2022
Intracerebroventricular dosing of N-sulfoglucosamine sulfohydrolase in mucopolysaccharidosis IIIA mice reduces markers of brain lysosomal dysfunction
Jenna Magat, Samantha Jones, Brian Baridon, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 2014
Delivery of an enzyme-IGFII fusion protein to the mouse brain is therapeutic for mucopolysaccharidosis type IIIB
Shih-Hsin Kan, Mika Aoyagi-Scharber, Steven Q Le, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 28) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 28 results.
Thrombosis and Haemostasis
|
May 5, 2007
A novel P2Y(12) adenosine diphosphate receptor antagonist that inhibits platelet aggregation and thrombus formation in rat and dog models
Yi-Xin Wang, Jon Vincelette, Valdeci da Cunha, et al.
Circulation
|
April 27, 2005
Fasudil, a Rho-kinase inhibitor, attenuates angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice by inhibiting apoptosis and proteolysis
Yi-Xin Wang, Baby Martin-McNulty, Valdeci da Cunha, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 8, 2011
1-(1-acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia
Sampath-Kumar Anandan, Heather Kay Webb, Dawn Chen, et al.
The Journal of Biological Chemistry
|
September 5, 2019
Intracerebroventricular enzyme replacement therapy with β-galactosidase reverses brain pathologies due to GM1 gangliosidosis in mice
Joseph C Chen, Amanda R Luu, Nathan Wise, et al.
Molecular Therapy. Methods & Clinical Development
|
July 1, 2017
Clearance of Heparan Sulfate and Attenuation of CNS Pathology by Intracerebroventricular BMN 250 in Sanfilippo Type B Mice
Mika Aoyagi-Scharber, Danielle Crippen-Harmon, Roger Lawrence, et al.
Drug Delivery and Translational Research
|
January 17, 2020
Translational studies of intravenous and intracerebroventricular routes of administration for CNS cellular biodistribution for BMN 250, an enzyme replacement therapy for the treatment of Sanfilippo type B
Anita Grover, Danielle Crippen-Harmon, Lacey Nave, et al.
The Journal of Biological Chemistry
|
October 28, 2022
Intracerebroventricular dosing of N-sulfoglucosamine sulfohydrolase in mucopolysaccharidosis IIIA mice reduces markers of brain lysosomal dysfunction
Jenna Magat, Samantha Jones, Brian Baridon, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 2014
Delivery of an enzyme-IGFII fusion protein to the mouse brain is therapeutic for mucopolysaccharidosis type IIIB
Shih-Hsin Kan, Mika Aoyagi-Scharber, Steven Q Le, et al.
Page
of 3